Quotes 5-day view Delayed Nyse
08/10/2022
08/11/2022
08/12/2022
08/15/2022
08/16/2022
Date
35.68(c)
35.86(c)
34.93(c)
34.11(c)
33.11(c)
Last
975 501
1 122 421
1 899 215
1 851 451
2 540 045
Volume
+1.51% +0.50% -2.59% -2.35% -2.93% Change
Estimated financial data (e) (USD)
Sales 2022
1 346 M - -
Net income 2022
-21,5 M - -
Net Debt 2022
273 M - -
P/E ratio 2022
-146x
Yield 2022
-
Sales 2023
1 700 M - -
Net income 2023
7,11 M - -
Net Debt 2023
253 M - -
P/E ratio 2023
276x
Yield 2023
-
Capitalization
3 035 M 3 035 M -
EV / Sales 2022
2,46x
EV / Sales 2023
1,93x
Nbr of Employees
3 500
Free-Float
89,8%
Evolent Health, Inc. is a health care company that delivers clinical and administrative solutions to payers and providers. The Company supports health systems and physician organizations as well as health plans to move their business models from traditional fee-for-service reimbursement to value-based care. The Company operates through two segments: Evolent Health Services and Clinical Solutions. Its Evolent Health...
Ratings of Evolent Health, Inc.
All news about EVOLENT HEALTH, INC.
08/16 INSIDER SELL : Evolent HealthMT
08/12 EVOLENT HEALTH : Unregistered Sales of Equity Securities - Form 8-KPU
08/12 EVOLENT HEALTH, INC. : Unregistered Sale of Equity Securities (form 8-K)AQ
08/10 Evolent Health to Participate in the CG Growth Conference PR
08/03 EVOLENT HEALTH, INC. : Other Events, Financial Statements and Exhibits (form 8-K)AQ
08/03 EVOLENT HEALTH, INC. Management's Discussion and Analysis of Financial Condition and R.. AQ
08/03 RBC Raises Price Target on Evolent Health to $44 From $40, Maintains Outperform Rating MT
08/03 BTIG Adjusts Evolent Health's Price Target to $50 From $45, Reiterates Buy Rating MT
08/03 Piper Sandler Adjusts Evolent Health's Price Target to $40 From $35, Reiterates Overwei.. MT
08/02 EVOLENT HEALTH : Q2 Earnings SnapshotAQ
08/02 TRANSCRIPT : Evolent Health, Inc., Q2 2022 Earnings Call, Aug 02, 2022CI
08/02 EVOLENT HEALTH, INC. : Entry into a Material Definitive Agreement, Results of Operations a..AQ
08/02 Evolent Health, Inc. Promotes Aammaad Shams to the Chief Accounting Officer and Control.. CI
08/02 Earnings Flash (EVH) EVOLENT HEALTH Reports Q2 EPS $0.10 MT
08/02 Earnings Flash (EVH) EVOLENT HEALTH Reports Q2 Revenue $319.9M MT
News in other languages on EVOLENT HEALTH, INC.
Analyst Recommendations on EVOLENT HEALTH, INC.
Walgreens Boots Alliance : weighing deal to buy Evolent Health - Bloomberg News
Chart EVOLENT HEALTH, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends EVOLENT HEALTH, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
7
Last Close Price
33,11 $
Average target price
47,17 $
Spread / Average Target
42,5%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
